Phase I study of humanized 3S193 (anti-Lewis-Y) antibody [monoclonal antibody-3S193] in patients with advanced colorectal carcinoma
Phase of Trial: Phase I
Latest Information Update: 27 Dec 2007
At a glance
- Drugs Monoclonal antibody 3S193 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Dec 2007 New trial record.